Zydus Receives US Approval for Schizophrenia Generic Medicine

Zydus Lifesciences Ltd announced that it has been granted final approval by the FDA to produce paliperidone extended-release tablets in doses of 1.5 mg, 3 mg, 6 mg, and 9 mg. Paliperidone extended-release tablets are prescribed for treating...

Aerogen and IARC Ink strategic MoU to transform respiratory care

Aerogen, a leading global company in acute-care aerosol drug delivery based in Ireland, partnered with the Indian Association of Respiratory Care (IARC) to advance respiratory therapy education and enhance patient care throughout India...

India's Pharma Exports expected to stay robust amid global slowdown

India's pharmaceutical and meditech sectors are projected to continue their growth momentum throughout the current fiscal year despite a global economic slowdown, A senior government official stated. Secretary Arunish Chawla announced on the...

Bayer and MOMA Therapeutics sign pact to develop oncology program

Bayer and MOMA Therapeutics, Inc., a biopharmaceutical company in the clinical stage that focuses on discovering and creating precise therapeutics, have declared a collaboration. This partnership involves an option and exclusive license agreement...

Zealand Pharma Receives FDA CRL for Pediatric Dasiglucagon

Zealand Pharma A/S, a biotech company specializing in peptide-based drugs, revealed that the FDA has issued a Complete Response Letter (CRL) for Part 1 of the NDA for dasiglucagon for treating hypoglycemia in children with CHI. The CRL is...

Aurigene Declares phase 1 study for novel autologous CAR-T cell therapy

Aurigene Oncology Limited, a subsidiary of Dr Reddy’s Laboratories Limited, is dedicated to developing innovative treatments for cancer and has released phase 1 findings for DRL-1801 in the SWASTH study - India's initial trial for a new CAR-T cell...

ModeX Therapeutics Secures $35 Mn BARDA supplement to develop antibodies

ModeX Therapeutics Inc, a biotechnology company under OPKO Health, Inc., reveals that it has received $35 million more in funding from BARDA, a branch of HHS responsible for Strategic Preparedness and Response in the US. The firm will start...

Boehringer Initiates phase III trials in MASH for survodutide

Boehringer Ingelheim, a biopharmaceutical company involved in human and animal health, revealed that the FDA has given Breakthrough Therapy status to survodutide (BI 456906), a dual glucagon/GLP-1 receptor agonist for treating adults with non...

Explosion-Proof Safety in Pharmaceutical Plants: Key Design Strategies to Protect Your Facility

In pharmaceutical plant design, explosion-proof safety management is a critical factor for ensuring safe and efficient operations. Given that pharmaceutical production often involves large quantities of flammable and explosive chemicals.

Amneal Pharmaceuticals to Funnel up to USD 200 Million in India

Amneal Pharmaceuticals, a US company, announced plans to pour USD 200 million (around Rs 1,680 crore) into India for constructing two new manufacturing units in Ahmedabad within the next four to five years. The company announced plans for two new...

© 2024 India Pharma Outlook. All Rights Reserved.